Rebirth of the God-level Xueba

Northern United Pharmaceutical finally selected the site of the factory in Hebei. Tomato Novel Network ☆w-w`w`． x-f`qxsw. com

The land in the capital is hard to find, even if it is outside the sixth ring road that no one wants, don't want to grant tens of thousands of acres of land in one go.

For more than 30 years since the founding of the People’s Republic of China, various units and departments have long since occupied the large plots of land. The remaining wilderness is not a reserve land left by the government, or there are various disputes. In addition, there are also state farms and logistics farms.

Although Hu Chi came from Qiao Ban and became the director of the Chemical Drug Promotion Office, the tens of thousands of acres of land in the suburbs of Beijing is still a bit too challenging.

Furthermore, why is a unit like Beifang United Pharmaceutical, which the grandfather and grandma do not love, get tens of thousands of acres of land in the suburbs of Beijing?

The workers who had trained in the barracks for almost two months took off the green uniforms and put on the gray work uniforms, and there was no more resistance.

It would be thankful to be able to keep the respectable profession of state-owned enterprise workers.

As for the cadres of the original enterprise, there are even more luck.

If they can return smoothly, there are already a small number of corporate cadres who have been disrupted and resettled. The companies, including North China Pharmaceutical, were originally super-compiled. If several companies were merged, the result was not to mention. Most of them had to wait for their jobs. If you find something to do, you will be lucky to get down to the county.

The 1980s was originally an era of super editing.

The old cadres who are unwilling to retire, the ordinary cadres who are normal and abnormally promoted, and the unlucky cadres who have been rehabilitated form an extremely large official era. It's not uncommon to have a principal and eleven deputies.

The so-called historical issues are just like this. Rehabilitation is a major policy. The rehabilitated cadres must naturally be arranged. The cadres who are promoted normally have to make way for the rehabilitated cadres without any reason. As for the old cadres not to retire, it is to help you and is the last light. Fever, before there is no mandatory retirement policy, everyone is loyal to the country.

To some extent, people in the 1980s were actually used to this phenomenon.

Sometimes, more deputies also formed short-term relative checks and balances.

That kind of dominant position was not easy for middle and high-level leaders in the 1980s. Apart from anything else, the old revolutions of the Red Army were still there. Even if young and middle-aged cadres were promoted, could they point to the old revolutions? Curse on the nose? The reverse is almost the same.

However, Yang Rui did not have such a concept, and he did not want the newly born Northern United Pharmaceutical Industry to be so bloated.

Hu Chi now trusts him so much, and he has driven away the redundant cadres with good faith. Not only that, the North United Pharmaceutical Industry is even lacking, especially in the grassroots posts, with a large number of vacancies. The posture of the workers who had just ended their military training was irritating enough.

The only thing that makes it difficult for workers, or some workers, to adapt, is the content of their current work.

"Why can someone install machines and build a factory? I'm going to feed the mice!" Fang Zhengye put on a white coat and rubber gloves, but he didn't have the joy of wearing new clothes at all.

"This is not called a mouse, but a Chinese hamster." Duan Chang, who had received temporary training, gave a casual sentence.

"There are too many rats in China. Can we raise them? I have never seen such a man." Fang Zhengye's unhappiness will not decrease at all.

The worker next to it said: "People use it to make medicine."

"Using rats as medicine, is it not nauseating? I would rather die than take it."

"Patients don't think like you think. The Chinese hamsters we have raised here can treat Gaucher's disease by extracting cells. It is said that hundreds of thousands of people around the world have this disease and will die within a few years." Duan Chang had a good temper, and it was because of his good temper that he was sent to this workshop. Those sect leaders who were about to turn the wrench at any moment have all gone to the machinery and manufacturing workshops.

"Then these hundreds of thousands of people are cured, our workshop will be abolished?" Another worker heard the chat, and got together.

Duan Chang shook his head: "If Gaucher's disease can't be cured, you can only take medicine to maintain it."

"Always eat?"

"Well, I can't stop."

"That's not a pot of medicine."

Fang Zhengye said: "The medicine jar is better than the ashes jar."

"Now you know what's going on. If it's OK, you can go to work if you understand it. I tell you, our workshop is the core workshop, don't you know? There is a lot to do in the future."

"At the core, it's not about raising mice." Fang Zhengye muttered, while disgustingly picked up the dustpan for feeding, and started feeding cage by cage.

The medicine for Gaucher's disease is the ovarian cells of Chinese hamsters that use recombinant DNA. After preliminary experiments, they can quickly enter the cell line culture stage. The so-called cell engineering is also.

However, raising mice is indeed a big project. So many domestic biological laboratories and pharmaceutical institutions actually have a lot of demand.

Later generations will have specialized factories to do this business. It is a technology-intensive and labor-intensive industry. Yang Ruishun has opened a project for Northern United Pharmaceutical, which can also be regarded as reducing the cost of biological researchers across the country.

In addition to the "core workshop", a large number of ordinary workshops have already entered a state of large-scale construction in full swing. ,

In order to feed the large number of workers in the Northern Pharmaceutical Industry, they basically inherited the previous pharmaceutical production. Although it is difficult to obtain high profits from the manufacture of a large number of common drugs, it is not bad to ensure a balance of income and expenditure.

In addition, the license for the production of medicines is also considered a scarce resource.

Pharmaceutical companies in the 1980s were state-owned enterprises. It was not difficult for everyone to apply for one or two licenses, and the value of licenses was not reflected. It's like a car owner in a small city who doesn't experience the rare experience of Beijing and Shanghai license plates.

This is the last state-owned enterprise aftertaste. In a few years, as the demand for licenses from private enterprises increases, let alone a warehouse license, a license for ammonia plus Huangmin rushes to the seven-figure asking price.

As an intangible asset, this is the advantage of Northern United Pharmaceutical. It's large-scale, can open more production lines, and can save more drug licenses. If you don't need it in the future, you can sell it at will, and you can update the equipment in the factory.

As for now, North United Pharmaceutical continues to use the old equipment from the original factory, and it can be regarded as a profit point in disguise. Even if the production line does not make money, the remaining licenses, or even the newly applied licenses, can always be exchanged for some money.

The Chinese cadres like this traditional business model very much. They have been doing this for decades, and they don’t think that making cold medicine is low-end. It is better than making traditional Chinese medicine. At least it is still hanging on the wall of our workshop. It’s a chemical formula.

On the other hand, Zeleca did not care about the first workshops built after spending the money.

They paid more than 30 million U.S. dollars ~www.wuxiaspot.com~ to exchange for 49% of the shares, but they did not give in for this simple product.

Zelikang is totally optimistic about the development of orphan drugs for Gaucher's disease. However, even with the standard of desferiprone, Zelikang would bet that Yang Rui would pass the second phase of the clinical trial.

Taking into account that desferiprone has completed all the milestones, so that the price is extremely high, Zelican still gives a considerable premium to the orphan drug for Gaucher's disease.

Regarding this, Yang Rui can only say: Those who believe in me make money.

Recombinant DNA technology, in 1986, is still quite cutting-edge and high-end, and it is basically not used for large-scale pharmaceuticals, and many laboratories are still exploring.

However, for Yang Rui, reorganizing DNA or something is too simple, OK?

It only took one night for Yang Rui to write down what he wanted.

If it were not to avoid shocking the world, he would still have to pretend to give guidance and enlightenment. This work would be directly subcontracted to the research dog.

...